Last reviewed · How we verify
NCT04021134
The Effects of Allogeneic SLET
trial in Limbal Stem-cell Deficiency in 30 participants. Status unknown.
1 July 2020
Quick facts
| Lead sponsor | National Taiwan University Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 5 July 2019 |
| Primary completion | 1 July 2020 |
| Estimated completion | 1 July 2025 |
| Sites | 2 locations across Taiwan |
Conditions studied
- Limbal Stem-cell Deficiency — all drugs for Limbal Stem-cell Deficiency →
Sponsor
National Taiwan University Hospital
Who can join
Adults 10 to 90, any sex, with Limbal Stem-cell Deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To investigate the effect of allogeneic SLET and re-epithelialization after allogeneic SLET.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Regenerative therapy for the Cornea.
Kumar A, Yun H, Funderburgh ML, Du Y. · · 2022 · cited 95× · PMID 34530154 · DOI 10.1016/j.preteyeres.2021.101011 -
Therapeutic Strategies for Restoring Perturbed Corneal Epithelial Homeostasis in Limbal Stem Cell Deficiency: Current Trends and Future Directions.
Masood F, Chang JH, Akbar A, Song A, et al · · 2022 · cited 26× · PMID 36291115 · DOI 10.3390/cells11203247 -
Targeting limbal epithelial stem cells: master conductors of corneal epithelial regeneration from the bench to multilevel theranostics.
Li S, Sun H, Chen L, Fu Y. · · 2024 · cited 16× · PMID 39198892 · DOI 10.1186/s12967-024-05603-y
Verify or expand the search:
- PubMed search for NCT04021134
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Limbal Stem-cell Deficiency
Currently open trials in the same condition.
- NCT04995926 — Labial Mucosal Epithelium Grafting for Corneal Limbus Substitution · NA · recruiting
- NCT03957954 — Stem Cell Therapy for Limbal Stem Cell Deficiency · Phase 1 · active not recruiting
Other National Taiwan University Hospital trials
Trials by the same sponsor.
- NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
- NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
- NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
- NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
- NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04021134 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
- Last refreshed: 18 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04021134.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing